Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)

Abroad (travel likely)RecruitingPHASE2

Conditions

Melanoma Stage Iv

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Westmead Hospital, Sydney, New South Wales, Australia

    Contact: Study coordinator (Matteo Carlino)
    Contact: Principal Investigator (Matteo Carlino)
  • Calvary Mater NewcastleHospital, Waratah, New South Wales, Australia

    Contact: Study coordinator (Andre van der Westhuizen)
  • Melanoma Institute Australia, Wollstonecraft, New South Wales, Australia

    Contact: Study coordinator (Maria Gonzalez) · maria.gonzalez@melanoma.org.au · +612 9911 7200
    Contact: Principal Investigator (Alexander Menzies)
  • Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

    Contact: Principal Investigator (Victoria Atkinson)
  • Royal Adelaide Hospital, Adelaide, South Australia, Australia

    Contact: Study coordinator (Michael Brown)
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

    Contact: Principal Investigator (Grant McArthur)
  • Alfred Hospital, Melbourne, Victoria, Australia

    Contact: Study coordinator (Andrew Haydon, MBBS)
  • Sir Charles Gairdner Hosptial, Perth, Western Australia, Australia

    Contact: Study coordinator (Tarek Meniawy)
  • Oslo Univesity Hospital Radiumhospitalet, Oslo, Oslo, Norway

Study leads
  • Georgina V Long, MBBS PhD

    Study Chair

    Melanoma Institute Australia